Discounted Cash Flow Rating

Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Nautilus Biotechnolgy, Inc. Common Stock (NAUT)

Laboratory Analytical Instruments

https://www.nautilus.bio

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.

2701 EASTLAKE AVE EAST
SEATTLE, WA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/10/2021

Market Cap

284,682,970

Shares Outstanding

124,950,000

Weighted SO

124,968,503

Total Employees

N/A

Upcoming Earnings

07/30/2024

Beta

1.0220

Last Div

0.0000

Range

2.19-4.0

Chg

-0.0400

Avg Vol

73561

Mkt Cap

284682970

Exch

NASDAQ

Country

US

Phone

206 333 2001

DCF Diff

2.4419

DCF

-0.1219

Div Yield

0.0000

P/S

34.6667

EV Multiple

-3.8126

P/FV

1.2091

Div Yield %

0.0000

P/E

-4.0848

PEG

-0.0408

Payout

0.0000

Current Ratio

19.6905

Quick Ratio

19.6905

Cash Ratio

2.8666

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

94.3676

CCC

-94.3676

Gross Margin

0.2337

Op Margin

-9.1693

Pretax Margin

-8.4805

Net Margin

-8.4805

Eff Tax Rate

-0.0246

ROA

-0.2553

ROE

-0.2711

ROCE

-0.2851

NI/EBT

1.0000

EBT/EBIT

0.9249

EBIT/Rev

-9.1693

Debt Ratio

0.1195

D/E

0.1386

LT Debt/Cap

0.1090

Total Debt/Cap

0.1217

Int Coverage

-24.3289

CF/Debt

-1.7594

Equity Multi

1.1592

Rec Turnover

0.0000

Pay Turnover

3.8679

Inv Turnover

0.0000

FA Turnover

0.2335

Asset Turnover

0.0301

OCF/Share

-0.4577

FCF/Share

-0.4772

Cash/Share

1.3361

OCF/Sales

-6.9850

FCF/OCF

1.0426

CF Coverage

-1.7594

ST Coverage

-15.0356

CapEx Coverage

-23.4509

Div&CapEx Cov

-23.4509

P/BV

1.2091

P/B

1.2091

P/S

34.6667

P/E

-4.0848

P/FCF

-4.7600

P/OCF

-4.9593

P/CF

-4.9593

PEG

-0.0408

P/S

34.6667

EV Multiple

-3.8126

P/FV

1.2091

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation